Vir Biotechnology VIR
NASDAQ VIR
$10.57 +0.14 (+1.34%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Cash & Current Investments (2018 - 2026)

Updated

Vir Biotechnology (VIR) reported Cash & Current Investments of $528.59 million for Q2 2026, down 11.7% from $598.75 million a year earlier but up 12.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Vir Biotechnology posted Cash & Current Investments of $460.94 million, down 48.8% from FY2024.

  • Cash & Current Investments has declined for three consecutive years, with a five-year compound annual growth rate of -9.0% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $901 million in FY2024 (-40.4%), $1.51 billion in FY2023 (-36.2%), $2.37 billion in FY2022 (+319.5%) and $565 million in FY2021 (-23.3%).
  • Five-year quarterly Cash & Current Investments spans a low of $460.94 million in Q4 2025 and a high of $2.37 billion in Q4 2022.
  • Year over year, Cash & Current Investments has now declined in each of the last 13 quarters, with an average decline of 38.9% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q4 2022 (growth of 319.5%); the low point was Q4 2025 (a decline of 48.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $470.44 million (Q1 2026), $460.94 million (Q4 2025) and $497.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Vir Biotechnology 1.79 Bn -169.51 Mn 238.95 Mn 528.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 528.59 Mn
Mar 31, 2026 470.44 Mn
Dec 31, 2025 460.94 Mn
Sep 30, 2025 497.83 Mn
Jun 30, 2025 598.75 Mn
Mar 31, 2025 790.94 Mn
Dec 31, 2024 901.00 Mn
Sep 30, 2024 908.96 Mn
Jun 30, 2024 1.15 Bn
Mar 31, 2024 1.15 Bn
Dec 31, 2023 1.51 Bn
Sep 30, 2023 1.69 Bn
Jun 30, 2023 1.83 Bn
Mar 31, 2023 2.23 Bn
Dec 31, 2022 2.37 Bn
Sep 30, 2022 2.32 Bn
Jun 30, 2022 2.16 Bn
Mar 31, 2022 1.21 Bn
Dec 31, 2021 565.00 Mn
Sep 30, 2021 770.08 Mn
API Access

Vir Biotechnology Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VIR&period=max&api_key=YOUR_API_KEY